Dr. Arterburn linked even short-term diabetes remission to less risk for microvascular kidney, eye, and limb diseases
Dr. David Arterburn talks about his studies with Kaiser and other systems to help a rapidly increasing population with severe obesity.
Study leader Dr. David Arterburn will use PCORnet, new national clinical research network, to speed results.
Dr. David Arterburn has new studies on the costs, care variation, and effect on life expectancy of bariatric surgery. The results could guide obesity care.
JAMA study focuses mostly on male VA patients with more diseases than in prior studies.
GHRI's Dr. David Arterburn talks about bariatric surgery research in December 2014.
JAMA study focuses mostly on male VA patients with more diseases than prior studies.
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.